Gastrimut 20 mg capsules

Spain
Brand name Gastrimut 20 mg capsules
Form capsules, hard, enteric-coated
Active substance / Dosage
OMEPRAZOLE · 20 mg
Prescription type Prescription Only Medicine
Registration number 59842
Gastrimut 20 mg capsules capsules, hard, enteric-coated

Package leaflet: Information for the user

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Gastrimut 20mg gastro-resistant hard capsules

Omeprazole

Read the entire leaflet carefully before you start taking this medicine.

  • Keep this leaflet as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only; do not give it to others, even if they have the same symptoms, as it may harm them.
  • If you think any of the side effects you experience is serious, or if you notice any side effects not listed in this leaflet, inform your doctor or pharmacist.

Contents of the leaflet:

  1. What Gastrimut is and what it is used for

  2. Before you take Gastrimut

  3. How to take Gastrimut

  4. Possible side effects

    1. How to store Gastrimut
  5. Further information

1. What Gastrimut is and what it is used for

Gastrimut contains the active substance omeprazole. It belongs to a group of medicines known as "proton pump inhibitors". These medicines work by reducing the amount of acid produced in the stomach.

Gastrimut is used to treat the following conditions:

In adults:

  • Gastroesophageal reflux disease (GERD). In this disorder, stomach acid passes into the esophagus (the tube connecting the throat to the stomach), causing pain, inflammation, and heartburn.
  • Ulcers in the upper part of the intestine (duodenal ulcer) or in the stomach (gastric ulcer).
  • Ulcers infected with a bacterium called "Helicobacter pylori". If you have this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal.
  • Ulcers caused by a group of medicines called NSAIDs (non-steroidal anti-inflammatory drugs). Gastrimut can also be used to help prevent ulcers in patients taking NSAIDs.
  • Excess stomach acid caused by a tumor in the pancreas (Zollinger-Ellison syndrome).

In children:

Children over 1 year of age and = 10 kg

  • Gastroesophageal reflux disease (GERD). In this disorder, stomach acid passes into the esophagus (the tube connecting the throat to the stomach), causing pain, inflammation, and heartburn. In children, symptoms of the disease may include regurgitation of stomach contents into the mouth, vomiting, and insufficient weight gain.

Children over 4 years of age and adolescents

  • Ulcers infected with a bacterium called "Helicobacter pylori". If your child has this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal.

2. Before taking Gastrimut

Do not take Gastrimut

  • if you are allergic (hypersensitive) to omeprazole or to any of the other components of Gastrimut, or if you are allergic to medicines containing proton pump inhibitors (e.g. pantoprazole, lansoprazole, rabeprazole, esomeprazole).
  • if you are taking a medicine containing nelfinavir (used for HIV infection).

If you are unsure, speak with your doctor or pharmacist before taking Gastrimut.

Take special care with Gastrimut

Gastrimut may mask the symptoms of other illnesses. Therefore, if you experience any of the following conditions before starting or during treatment with Gastrimut, consult your doctor immediately:

  • Unintentional weight loss and difficulty swallowing.
  • Stomach pain or indigestion.
  • You begin vomiting food or vomiting blood.
  • Your bowel movements are black (blood-stained stools).
  • You have severe or persistent diarrhoea, as omeprazole has been associated with a slight increase in infectious diarrhoea.
  • You have severe liver problems.
  • You have ever had a skin reaction after treatment with a medicine similar to Gastrimut used to reduce stomach acid.

If you develop a skin rash, especially in areas of skin exposed to sunlight, consult your doctor as soon as possible, as treatment with Gastrimut may need to be discontinued. Remember to mention any other symptoms you may notice, such as joint pain.

If you take Gastrimut for a long period (more than 1 year), your doctor will likely perform periodic check-ups. You should report any new or unusual symptoms or circumstances during each visit to your doctor.

Use of other medicines

Inform your doctor or pharmacist if you are currently using, or have recently used, any other medicines, including those obtained without a prescription. Gastrimut may affect the action of certain medicines, and some medicines may affect Gastrimut.

Do not take Gastrimut if you are taking a medicine containing nelfinavir (used to treat HIV infection).

Inform your doctor or pharmacist if you are taking any of the following medicines:

  • Ketoconazole, itraconazole, or voriconazole (used to treat fungal infections)
  • Digoxin (used to treat heart problems)
  • Diazepam (used to treat anxiety, to relax muscles, or in epilepsy)
  • Phenytoin (used in epilepsy). If you are taking phenytoin, your doctor will need to monitor you when starting or stopping treatment with Gastrimut
  • Medicines used to prevent blood clots, such as warfarin or other vitamin K antagonists. Your doctor will need to monitor you when starting or stopping treatment with Gastrimut
  • Rifampicin (used to treat tuberculosis)
  • Atazanavir (used to treat HIV infection)
  • Tacrolimus (used in organ transplantation)
  • St. John’s wort (Hypericum perforatum) (used to treat mild depression)
  • Cilostazol (used to treat intermittent claudication)
  • Saquinavir (used to treat HIV infection)
  • Clopidogrel (used to prevent blood clots (thrombi))

If your doctor has prescribed, in addition to Gastrimut, the antibiotics amoxicillin and clarithromycin to treat ulcers caused by Helicobacter pylori infection, it is very important that you inform them about any other medicines you are taking.

Warnings and precautions

Before taking this medicine, tell your doctor if:

  • You are scheduled to have a specific blood test (chromogranin A)

When taking omeprazole, kidney inflammation may occur. Signs and symptoms may include reduced urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should report these signs to your treating doctor.

Taking Gastrimut with food and drinks

You may take your capsules with food or on an empty stomach.

Pregnancy and breastfeeding

Before taking Gastrimut, inform your doctor if you are pregnant or trying to become pregnant. Your doctor will decide whether you can take Gastrimut during this time.

Your doctor will decide whether you can take Gastrimut while breastfeeding.

Driving and using machines

Gastrimut is unlikely to affect your ability to drive or operate tools or machinery. However, adverse effects such as dizziness and visual disturbances may occur (see section 4). If these occur, you should not drive or operate machinery.

Gastrimut contains lactose, sucrose, glucose, and sodium.

This medicine contains lactose, sucrose, and glucose. If your doctor has informed you that you have an intolerance to certain sugars, consult with them before taking this medicine.

This medicine contains less than 23 mg of sodium (1 mmol) per capsule; this is essentially “sodium-free.”

3. How to take Gastrimut

Follow exactly the administration instructions for Gastrimut given by your doctor. Consult your doctor or pharmacist if you have any doubts.

Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and your age.

The usual doses are indicated below.

Adults:

Treatment of GERD symptoms, such as heartburn and acid regurgitation:

  • If your doctor confirms you have mild damage to the esophagus, the usual dose is 20 mg once daily for 4–8 weeks. Your doctor may prescribe a dose of 40 mg for another 8 weeks if the esophagus has not yet healed.

  • The usual dose once the esophagus has healed is 10 mg once daily.

  • If you do not have esophageal damage, the usual dose is 10 mg once daily.

Treatment of ulcers in the upper intestine (duodenal ulcer):

  • The usual dose is 20 mg once daily for 2 weeks. Your doctor may prescribe the same dose for another 2 weeks if the ulcer has not yet healed.
  • If the ulcer does not heal completely, the dose may be increased to 40 mg once daily for 4 weeks.

Treatment of stomach ulcers (gastric ulcer):

  • The usual dose is 20 mg once daily for 4 weeks. Your doctor may prescribe the same dose for another 4 weeks if the ulcer has not yet healed.
  • If the ulcer does not heal completely, the dose may be increased to 40 mg once daily for 8 weeks.

Prevention of recurrence of stomach and duodenal ulcers:

  • The usual dose is 10 mg or 20 mg once daily. Your doctor may increase the dose to 40 mg once daily.

Treatment of stomach and duodenal ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs):

  • The usual dose is 20 mg once daily for 4–8 weeks.

Prevention of stomach and duodenal ulcers during NSAID treatment:

  • The usual dose is 20 mg once daily.

Treatment of ulcers caused by Helicobacter pylori infection and prevention of their recurrence:

  • The usual dose is 20 mg of Gastrimut twice daily for one week.

  • Your doctor will also instruct you to take two of the following antibiotics: amoxicillin, clarithromycin, and metronidazole.

Treatment of excess stomach acid caused by a tumor in the pancreas (Zollinger-Ellison syndrome):

  • The usual dose is 60 mg per day.
  • Your doctor will adjust the dose according to your needs and will also decide for how long you need to take the medicine.

Children:

Treatment of GERD symptoms, such as heartburn and acid regurgitation:

  • Children over one year of age who weigh more than 10 kg may take omeprazole. The dose for children is based on body weight, and the doctor will determine the correct dose.

Treatment of ulcers caused by Helicobacter pylori infection and prevention of their recurrence:

  • Children over 4 years of age may take omeprazole. The dose for children is based on body weight, and the doctor will determine the correct dose.
  • Your doctor will also prescribe two antibiotics for your child: amoxicillin and clarithromycin.

How to take this medicine

  • It is recommended to take the capsules in the morning.
  • You may take your capsules with food or on an empty stomach.
  • Swallow the capsules whole with half a glass of water. Do not chew or crush the capsules, as they contain coated granules that prevent the medicine from breaking down due to stomach acid. It is important not to damage the granules.

What to do if you or your child have difficulty swallowing the capsules

  • If you or your child have difficulty swallowing the capsules:
    • Open the capsule and swallow the contents directly with half a glass of water, or pour the contents into a glass of still water, acidic fruit juice (e.g., apple, orange, or pineapple), or apple puree.
    • Always shake the mixture well just before drinking it (the mixture will not be clear). Then drink the mixture immediately or within 30 minutes.
    • To ensure you have taken all the medicine, fill the glass halfway with water, swirl it well, and drink the water. The solid particles contain the medicine; do not chew or crush them.

If you take more Gastrimut than you should

If you have taken more Gastrimut than prescribed by your doctor, contact your doctor or pharmacist immediately. You may also call the Toxicology Information Service at telephone number 91 562 04 20, stating the medicine and the amount ingested.

If you forget to take Gastrimut

If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose. Do not take a double dose to make up for a missed dose.

4. Possible adverse effects

Like all medicines, Gastrimut may cause adverse effects, although not everyone will experience them.

If you notice any of the following rare but serious adverse effects, stop taking Gastrimut and consult your doctor immediately:

  • Sudden wheezing, swelling of the lips, tongue and throat or of the body, skin rash, fainting or difficulty swallowing (severe allergic reaction).
  • Skin redness with blistering or peeling. Severe blisters and bleeding in the lips, eyes, mouth, nose, and genitals may also occur. This could be "Stevens-Johnson syndrome" or "toxic epidermal necrolysis".
  • Yellowing of the skin, dark urine, and fatigue, which may be symptoms of liver problems.

Adverse effects may occur with certain frequencies, defined as follows:

Very common:

affect more than 1 in 10 patients

Common:

affect 1 to 10 patients in 100

Uncommon:

affect 1 to 10 patients in 1,000

Rare:

affect 1 to 10 patients in 10,000

Very rare:

affect less than 1 patient in 10,000

Frequency not known:

cannot be estimated from the available data

Other adverse effects are:

Frequent adverse effects

  • Headache.
  • Stomach or intestinal problems: diarrhoea, stomach pain, constipation, and gas (flatulence).
  • Nausea or vomiting.
  • Benign polyps in the stomach.

Uncommon adverse effects

  • Swelling of the feet and ankles.
  • Sleep disturbances (insomnia).
  • Dizziness, tingling sensation, drowsiness.
  • Sensation of spinning (vertigo).
  • Abnormal blood test results used to assess liver function.
  • Skin rash, hives, and itching.
  • General malaise and lack of energy.

Rare adverse effects

  • Blood disorders, such as a decrease in white blood cells or platelets. This may cause weakness or bruising and increase the likelihood of developing infections.
  • Allergic reactions, sometimes severe, including swelling of the lips, tongue, and throat, fever, and wheezing.
  • Low sodium concentration in the blood. This may cause weakness, vomiting, and cramps.
  • Restlessness, confusion, or depression.
  • Taste disturbances.
  • Visual problems, such as blurred vision.
  • Sudden sensation of difficult breathing (bronchospasm).
  • Dry mouth.
  • Inflammation inside the mouth.
  • Fungal infection called “candidiasis” that may affect the intestine.
  • Liver problems, such as jaundice, which may cause yellowing of the skin, dark urine, and fatigue.
  • Hair loss (alopecia).
  • Skin rash upon exposure to sunlight.
  • Joint pain (arthralgia) or muscle pain (myalgia).
  • Serious kidney problems (interstitial nephritis).
  • Increased sweating.

Very rare adverse effects

  • Blood count abnormalities, such as agranulocytosis (lack of white blood cells).
  • Aggressiveness.
  • Seeing, feeling, or hearing things that do not exist (hallucinations).
  • Severe liver problems leading to liver failure and brain inflammation.
  • Sudden onset of severe rash, blistering, or skin peeling. This may be accompanied by high fever and joint pain (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis).
  • Muscle weakness.
  • Enlargement of the breasts in males.

In very rare cases, Gastrimut may affect white blood cells and cause immunodeficiency. If you develop an infection with symptoms such as fever accompanied by a very poor general condition, or fever with signs of local infection such as neck, throat, or mouth pain, or difficulty urinating, you should consult your doctor as soon as possible for a blood test to rule out a deficiency in white blood cells (agranulocytosis). It is important that you provide information about the medication you are taking at that time.

Adverse effects of unknown frequency

If you are taking Gastrimut 20 mg gastro-resistant hard capsules for more than three months, magnesium levels in the blood may decrease. Low magnesium levels can cause fatigue, involuntary muscle contractions, disorientation, seizures, dizziness, and increased heart rate. If you experience any of these symptoms, seek medical attention immediately. Low magnesium levels may also lead to decreased levels of potassium and calcium in the blood. Your doctor may decide to perform periodic blood tests to monitor your magnesium levels.

Skin rash, possibly with joint pain.

If you are taking proton pump inhibitors such as Gastrimut 20 mg gastro-resistant hard capsules, especially for a period longer than one year, the risk of fractures of the hip, wrist, and spine may slightly increase. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).

Do not be alarmed by this list of possible adverse effects. You may not experience any of them. If you consider any of the adverse effects you experience to be severe, or if you notice any adverse effect not listed in this leaflet, inform your doctor or pharmacist.

5. Storage of Gastrimut

  • Keep this medicine out of the sight and reach of children.

  • Do not use Gastrimut after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

  • Store below 30°C.

Keep the blister pack in the original packaging to protect it from moisture.

  • Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their packaging at the SIGRE Point at your pharmacy. If you have any doubts, ask your pharmacist how to properly dispose of unused medicines and their packaging. This will help protect the environment.

6. ADDITIONAL INFORMATION

Composition of Gastrimut

  • The active substance is omeprazole. Gastrimut capsules contain 20 mg of omeprazole.

The other components (excipients) are: sucrose; corn starch; hypromellose phthalate, hydroxypropyl methylcellulose (hypromellose), lactose, glucose, sodium lauryl sulfate, diethyl phthalate and sodium hydrogen phosphate dihydrate.

The gelatin capsule consists of: gelatin, erythrosine (E-127), indigo carmine (E-132) and titanium dioxide (E-171).

Appearance of the product and contents of the container

Gastrimut 20 mg capsules consist of a body and cap, colored white and red.

Pack sizes: blisters of 14, 28, 56 and 500 capsules.

Marketing Authorization Holder and Manufacturer

LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)

This leaflet was last revised in: March 2023

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/